NightHawk Biosciences, Inc. logo

NightHawk Biosciences, Inc.


Overview | Financials
Company Name NightHawk Biosciences, Inc.
Symbol NHWK
Currency USD
Price 0.442
Market Cap 11,517,767
Dividend Yield 0%
52-week-range 0.36 - 1.52
Industry Biotechnology
Sector Healthcare
CEO Mr. Jeffrey Alan Wolf J.D.

An error occurred while fetching data.

About NightHawk Biosciences, Inc.

NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator

Related Stocks


Numbers are in millions USD

Numbers are in millions USD